ASCO 2022 Conference Coverage
Playback speed
10 seconds
ASCO 2022 on EFS by Residual Cancer Burden After Neoadjuvant Pembro + Chemo vs. Placebo + Chemo for eTNBC: Exploratory Analysis From the KEYNOTE-522
By
ASCO 2022 Conference Coverage
FEATURING
Lajos Pusztai
By
ASCO 2022 Conference Coverage
FEATURING
Lajos Pusztai
1,964 views
June 14, 2022
Login to view comments.
Click here to Login
Breast